Valuation Zai Lab Limited Hong Kong S.E.

Stocks

Market Closed - Hong Kong S.E. Other stock markets 01:38:21 29/07/2026 pm IST			5-day change	1st Jan Change
14.40 ^HKD	-3.68%		-9.55%	+5.49%

30/06	Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing	MT
16/06	Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,059	2,946	2,688	2,853	1,962	2,057	-	-
Change	-	-51.37%	-8.77%	6.15%	-31.23%	4.86%	-	-
Enterprise Value (EV) ¹	4,650	1,938	1,897	2,095	1,397	1,564	1,686	1,783
Change	-	-58.33%	-2.13%	10.47%	-33.34%	11.97%	7.81%	5.76%
P/E	-8.29x	-6.63x	-7.9x	-10.1x	-11x	-8.16x	-9.74x	-12.5x
PBR	4.35x	-	3.34x	3.36x	2.73x	3.9x	4.37x	4.9x
PEG	-	0.2x	0.3x	0.4x	0.3x	-0.2x	0.6x	0.6x
Capitalization / Revenue	42x	13.7x	10.1x	7.15x	4.26x	4.6x	3.46x	2.74x
EV / Revenue	32.2x	9.01x	7.11x	5.25x	3.04x	3.49x	2.84x	2.37x
EV / EBITDA	-6.7x	-4.89x	-5.3x	-7.75x	-6.51x	-6.35x	-10.3x	-23.2x
EV / EBIT	-6.64x	-4.79x	-5.17x	-7.43x	-6.09x	-5.99x	-9.58x	-19.5x
EV / FCF	-8.19x	-4.94x	-9.23x	-9.5x	-8.5x	-8.89x	-14.6x	-25.4x
FCF Yield	-12.2%	-20.2%	-10.8%	-10.5%	-11.8%	-11.2%	-6.87%	-3.94%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-7.58	-4.63	-3.46	-2.6	-1.6	-2.244	-1.88	-1.464
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	144.3	215	266.7	399	460.2	447.6	594.6	751.5
EBITDA ¹	-693.6	-396.1	-357.5	-270.3	-214.4	-246.2	-163.3	-76.84
EBIT ¹	-700.1	-404.4	-366.6	-282.1	-229.4	-260.9	-175.9	-91.43
Net income ¹	-704.5	-443.3	-334.6	-257.1	-175.5	-244.1	-158.9	-136.3
Net Debt ¹	-1,409	-1,008	-791.3	-757.9	-565.3	-493.5	-371.4	-274.2
Reference price ²	62.85	30.70	27.33	26.19	17.64	18.31	18.31	18.31
Nbr of stocks (in thousands)	96,409	95,972	98,349	1,08,937	1,11,219	1,12,355	-	-
Announcement Date	01/03/22	01/03/23	27/02/24	27/02/25	26/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.39x	3.96x	10.22x	0.56%	7.07TCr
UCB	26.81x	5.55x	16.3x	0.59%	5.43TCr
SAMSUNG BIOLOGICS CO.,LTD.	37.72x	12.9x	24.55x	-.--%	4.93TCr
CSL LIMITED	-44.25x	3.17x	9.36x	3.41%	3.99TCr
BIOGEN INC.	25.48x	3.48x	11.99x	-.--%	3.04TCr
INCYTE CORPORATION	61.3x	3.69x	34.6x	-.--%	2.6TCr
MODERNA, INC.	-6.44x	8.96x	-5.51x	-.--%	2.21TCr
INNOVENT BIOLOGICS, INC.	64.91x	6.37x	43.87x	-.--%	2TCr
BRIDGEBIO PHARMA, INC.	-38.46x	18.32x	-50.14x	-.--%	1.68TCr
Average	16.16x	7.38x	10.58x	0.51%	3.66TCr
Weighted average by Cap.	17.36x	6.61x	13.25x	0.63%